Biesma, Hedde D.
Soeratram, Tanya T. D.
Sikorska, Karolina
Caspers, Irene A.
van Essen, Hendrik F.
Egthuijsen, Jacqueline M. P.
Mookhoek, Aart
van Laarhoven, Hanneke W. M.
van Berge Henegouwen, Mark I.
Nordsmark, Marianne
van der Peet, Donald L.
Warmerdam, Fabienne A. R. M.
Geenen, Maud M.
Loosveld, Olaf J. L.
Portielje, Johanneke E. A.
Los, Maartje
Heideman, Daniëlle A. M.
Meershoek-Klein Kranenbarg, Elma
Hartgrink, Henk H.
van Sandick, Johanna
Verheij, Marcel
van de Velde, Cornelis J. H.
Cats, Annemieke
Ylstra, Bauke
van Grieken, Nicole C. T. http://orcid.org/0000-0001-9992-0760
Funding for this research was provided by:
Cancer Center Amsterdam
ZonMw (848101003)
Article History
Received: 18 September 2021
Accepted: 17 January 2022
First Online: 7 February 2022
Declarations
:
: AM received speaker fees from Pfizer and Roche. HWMvL has served in a consultant or advisory role for BMS, Daiichi, Lilly, MSD, Nordic Pharma, Novartis, Servier, and received funding for research or study medication from Bayer, BMS, Celgene, Janssen, Lilly, Merck, Nordic Pharma, Philips, Roche, Servier, and received research grants from the Dutch Cancer Society, Dutch Research Council, European Research Council, MaagLeverDarm Stichting, all fees paid to the institution and unrelated to the present study. MIvBH has served in a consultant or advisory role for Medtronic, Mylan, Alesi Surgical, Johnson and Johnson, BBraun, and received research grants from Olympus, Stryker, all fees paid to the institution and unrelated to the present study. DAMH has served on the speaker’s bureau of QIAGEN and occasionally on the scientific advisory boards of Pfizer and Bristol-Myers Squibb. DAMH is a minority shareholder of Self-screen B.V., a spin-off company of VUmc. Self-screen B.V. holds patents and develops, manufactures and licenses high-risk HPV and methylation marker assays. AC received research grants form Dutch Cancer Society, Dutch Colorectal Cancer Group, Hofmann-La Roche, all fees paid to the institute and unrelated to the present study. NCTvG has served on the advisory boards of BMS and MSD. Topics were not related to the present study. NCTvG received research grants from Cancer Center Amsterdam and The Netherlands Organization for Health Research and Development (ZonMW) [848101003], all fees paid to the institute, but related to the present study. The remaining authors declare that they have no conflict of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
: Informed consent to be included in the study, or the equivalent, was obtained from all patients.